Celebrity Inventors
Superstar singer Michael Jackson co-patented a "Method and means for creating anti-gravity illusion" in 1993.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7368131 | Method and composition for treating hypopigmentation of the hair and skin A method of treating disorders marked by a loss of pigmentation, comprising the step of administering vitamin B12, copper, folic acid, and vitamin C to a patient suffering from a loss of pigmentation. Additionally, an effective amount of both pantothenic acid and zi... | 05/06/2008 |
| 7342122 | Bisphosphonate complexes Bisphosphonate compounds are disclosed, particularly bisphosonate conjugates useful in the treatment of soft tissues surrounding bone and bone-related diseases, such as bone cancer and osteoporosis. ... | 03/11/2008 |
| 7316810 | Foaming composition for washing and treating hair and/or scalp based on an active principle The invention concerns a foaming composition for washing and treating hair and/or scalp essentially characterized in that it contains in an aqueous medium: at least an active principle selected among corticoids and retinoids; at least an anionic surfactant; at least... | 01/08/2008 |
| 7303765 | Ultrafine-L-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same L-carnitine which has a particle size such that it substantially passes through a 100 USBS mesh sieve exhibits an increased bioavailability, a decreased hygroscopicity, and may be conveniently formulated with oil-based materials. ... | 12/04/2007 |
| 7288525 | Method for lowering serum homocysteine The present invention provides a method for reducing the amount of homocysteine in the blood of an individual. The method comprises administering to the individual a composition comprising a homocysteine lowering agent in an amount effective to lower the amount of h... | 10/30/2007 |
| 7279180 | Stable emulsions and dry powders of mixtures of fat-soluble vitamins, their preparation and use The present invention relates to stable emulsions and dry powders of mixtures of fat-soluble vitamins, and to processes for their preparation and to their use. ... | 10/09/2007 |
| 7273607 | Health enhancement method A health enhancement system establishing a health enhancement program through which may be provided a group of natural products, vitamins and minerals, amino acids, herbs and essential oils that may be helpful in aiding the body in fighting the growth of cancers and... | 09/25/2007 |
| 7262224 | Cosmetic rejuvenating and healing product, method of its manufacture and uses thereof A cosmetic composition is shown for rejuvenating the appearance of skin with reduced or minimal potential for skin irritation, in the form of a lotion or cream which includes as a major component aloe vera as well as vitamins A, B, C, D and E. ... | 08/28/2007 |
| 7259143 | Method of extending the dose range of vitamin D compounds Inhibitors of bone calcium resorption are administered to allow high doses of vitamin D compounds or mimetics to be given with the intent of treating non-calcium related diseases such as cancer, psoriasis, and autoimmune disease without the dangers of calcification ... | 08/21/2007 |
| 7241755 | Epothilone derivatives The present invention relates to compounds of the formula in which the variables G, W, Q, X, Y, B1, B2, Z1, Z2, and R1–R7 are as defined herein,... | 07/10/2007 |
| 7214709 | Arginine/ascorbic acid mixed powder as an oral supplement A mixture obtained by mixing ascorbic acid powder with arginine powder in a weight ratio (ascorbic acid/arginine) of 1/5 to 20, especially 1/5 to 1/4; and a supplement such as a nutrient preparation and a health-care food containing the mixture. Mixing of arginine p... | 05/08/2007 |
| 7148211 | Formulation for lipophilic agents The invention relates to pharmaceutical formulations of lipophilic therapeutic agents in which such agents are solubilized in largely aqueous vehicles, and processes for preparing and using the same. ... | 12/12/2006 |
| 7144586 | Compositions for preventing hormone induced adverse effects A unit dosage form suitable for once daily administration to a human comprising a physiologically effective amount of at least one hormone selected from the group consisting of steroidal estrogen, estradiol, estrone, medroxyprogesterone, norethindrone, norethisteron... | 12/05/2006 |
| 7125899 | Epothilone derivatives The present invention relates to epothilone derivatives, having the following formula: in which the variables G, W, Q, X, Y, B1, B2, Z1, Z2, and R1–R7... | 10/24/2006 |
| 7122530 | 24-hydroxyvitamin D, analogs and uses thereof The invention provides 24-hydroxyvitamin D compounds and methods for their use in the treatment and prophylaxis of hyperparathyroidism and hyperproliferative diseases, and in the modulation of the immune and inflammatory responses as well as the treatment of bone de... | 10/17/2006 |
| 7119110 | Method and composition for preventing or reducing the symptoms of insulin resistance syndrome A method for preventing and or reducing the symptoms of insulin resistance and a related syndrome in persons comprises identifying persons having or at risk for having such symptoms, and administering to them an effective amount of a composition comprising niacin-bo... | 10/10/2006 |
| 7112579 | 26,27-Homologated-20-EPI-2-alkyl-19-nor-vitamin D compounds This invention provides a novel class of vitamin D related compounds, namely, the 2-alkyl-19-nor-vitamin D derivatives, as well as a general method for their chemical synthesis. The compounds have the formula: wh... | 09/26/2006 |
| 7101578 | Salt sorbet facial and body scrub The present invention is a salt sorbet facial and body scrub which has enhanced properties to deep clean skin, exfoliate dead skin cells in an efficient manner, and at the same time not damage sensitive skin, especially on a woman's face. It is an object of the pres... | 09/05/2006 |
| 7094774 | 26,27-homologated-20-epi-2-alkylidene-19-nor-vitamin D compounds This invention provides a novel class of vitamin D related compounds, namely, the 2-alkylidene-19-nor-vitamin D derivatives, as well as a general method for their chemical synthesis. The compounds have the formula: | 08/22/2006 |
| 7094775 | Method of treating breast cancer using a combination of vitamin D analogues and other agents The invention provides therapeutic methods for inhibiting, ameliorating or alleviating the hyperproliferative cellular activity of diseases of the breast, e.g., breast cancer, which includes administering to a patient in need thereof an active vitamin D analogue and... | 08/22/2006 |
| 7078059 | Treatment of bone diseases The invention provides a method for enhancing bone formation, inhibiting osteoclastic differentiation and/or activating osteoblastic differentiation whereby to manage, treat or achieve prophylaxis of bone disease which comprises administering to a human or animal su... | 07/18/2006 |
| 7041286 | Composition for mitigating a pernicious thrombotic event A composition. The composition comprises aspirin, magnesium, and nattokinase, and either niacin or nitroglycerine. The composition has a structural form of: a chewable form, a dissolvable form, a liquid form, a spray form, or a suppository form. The structural form ... | 05/09/2006 |
| 7034012 | Composition and method for prevention and treatment of arrhythmias A composition of biochemical substances for the treatment of arrhythmia in a human susceptible to arrhythmia, and its method of administration, comprising at least one ascorbate compound selected from the group consisting of ascorbic acid, pharmaceutically acceptabl... | 04/25/2006 |
| 7029703 | Composition for promoting healthy bone structure A dietary supplement for benefitting human bone health includes a calcium source, a source of vitamin D activity, and an osteoblast stimulant. A preferred calcium source is microcrystalline hydroxyapatite, which also contains protein (mostly collagen), phosphorus, f... | 04/18/2006 |
| 6979454 | Biologically active composition A biologically active stick composition comprising a biologically active agent dissolved in a carrier system including an unsaturated fatty acid alcohol in mutual dissolution with an alkylene glycol as a solvent for said biologically active agent and a stiffening ag... | 12/27/2005 |
| 6953571 | Cosmetic or pharmaceutical composition for topical use to prevent or differ androgenetic alopecia A cosmetic-pharmaceutical composition for topical use against human alopecia containing a pool of enzymes of the specific hydroxisteroido-dehydrogenase group in the presence of nicotinamido-adenine-dinucleotide coenzyme and a vasodilator, the whole being complexed w... | 10/11/2005 |
| 6930099 | Composition for the treatment and prevention of endothelial dysfunction This invention relates to a method and compositions for the treatment and prevention of disorders associated with endothelial dysfunction consisting of anti-inflammatory agents and dietary supplements. ... | 08/16/2005 |
| 6867234 | Fat composition for oral or enternal administration and hexacosanoic acid depressant A fat composition for oral or enteral administration which contains eicosapentaenoic acid and/or a derivative thereof, docosahexaenoic acid and/or a derivative thereof, and a C20 or higher monoenoic acid and/or a derivative thereof and functions to dimini... | 03/15/2005 |
| 6867024 | Ubiquinone composition and methods related thereto A composition is provided that includes an ubiquinone, such as CoQ10, bound by a glycoprotein matrix. A method is also provided for the manufacture of a composition of the invention. The glycoprotein matrix can be formed by permitting the growth of glycop... | 03/15/2005 |
| 6863904 | Compositions and methods for prophylactic and therapeutic supplementation of nutrition in subjects The present invention relates to compositions without added iron and methods for prophylactic nutritional supplementation and therapeutic nutritional supplementation. Specifically, the method involves administering to an individual a composition comprising carotenoi... | 03/08/2005 |
| 6864247 | Therapeutic agents for glomerulosclerosis An object of the present invention is to provide pharmaceutical compositions for inhibiting mesangial cell proliferation or mesangial matrix production without causing hypercalcemia. According to the present invention, therapeutic agents for glomerulosclerosi... | 03/08/2005 |
| 6806069 | Ubiquinone composition and methods related thereto A composition is provided that includes an ubiquinone, such as CoQ10, bound by a glycoprotein matrix. A method is also provided for the manufacture of a composition of the invention. The glycoprotein matrix can be formed by permitting the growth of glycop... | 10/19/2004 |
| 6790462 | Calcium dietary supplement A dietary supplement composition contains phosphorus and from greater than 1.3 to less than 2.2 parts by weight calcium per part by weight phosphorus, and may, optionally, further contain Vitamin D, Vitamin B12, folate and Vitamin B6, provides ... | 09/14/2004 |
| 6774111 | Carbohydrate system and a method for providing nutrition to a diabetic The two carbohydrate mixture of this invention utilizes a source of fructose in combination with at least one readily digestible glucose polymer source. The addition of the fructose significantly decreases the glycemic response when compared to the digestible glucos... | 08/10/2004 |
| 6761912 | Composition for increasing bone density A composition and a method for administering an improved supplement to prevent bone density loss. The composition combines a calcium compound with inulin, and optionally magnesium, Vitamin D3, Vitamin K, Vitamin C, and may combine a soy isoflavone, all in... | 07/13/2004 |
| 6740676 | 4-[(8-ETHYNYL, 8-VINYL OR 8-ETHYNYL-METHYL)-6-CHROMANOYL]-BENZOIC AND 2-[4-[(8-ETHYNYL, 8-VINYL OR 8-ETHYNYL-METHYL)-6-CHROMANOYL]-PHENYL]-ACETIC ACID, THEIR ESTERS AND SALTS HAVING CYTOCHROME P450RAI INHIBITORY ACTIVITY Compounds of Formula 1: wherein the variables are defined in the specification have cytochrome P450RAI-1 and P450RAI-2 inhibitory activity, and are suitable for treatment of mammals with conditions which are treatable wi... | 05/25/2004 |
| 6730308 | Tazarotene and alpha hydroxy acid treatment for psoriasis and/or photodamage The present invention relates to a method of treating psoriasis and/or photo damage in humans with tazarotene in a topical composition from 0.01 to 15% by weight tazarotene, and an alpha or beta-hydroxy acid in a topical composition comprising from 1 to 25% by weigh... | 05/04/2004 |
| 6686340 | Composition and method for prevention and treatment of health conditions caused by constriction of smooth muscle cells The invention relates to a method of administering to a human subject a composition comprising a vitamin, an amino acid and a trace element for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of th... | 02/03/2004 |
| 6680309 | Method of treating hyperproliferative diseases using active vitamin D analogues Methods for the utilization of hypocalcemic vitamin D analogs to inhibit the hyperproliferation of malignant or neoplastic cells without incidence of hypercalcemia.... | 01/20/2004 |
| 6624154 | Compositions and methods for treatment of hyperproliferative diseases The invention relates to compositions comprising a retinoid X receptor agonist and an agent capable of activating protein kinase A. The invention also relates to methods of treating hyperproliferative diseases by administering a retinoid X receptor agonis... | 09/23/2003 |
